Insider · CIK 0001244828
Keith S Manchester
Files at ROIV (Roivant Sciences Ltd.). First filing Nov 21, 2025, latest Jun 30, 2026.
Keith S Manchester files SEC Form 4 as director at ROIV (Roivant Sciences Ltd.). Since Nov 21, 2025, Keith S Manchester has reported 0 open-market buys worth $0 and 4 open-market sells worth $154M, the latest filed on Jun 30, 2026.
A track record needs three past buys with six months of prices behind them; Keith S Manchester has 0, so none is measured yet.
The newest scored trade: sold $56M of ROIV on Jun 26, 2026, filed Jun 30, 2026, scored 60 (notable). In the last 12 months: 0 buys worth $0 and 4 sells worth $154M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ROIV: Roivant Sciences Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Roivant Sciences Ltd. | $56M 1,638,163 shares | -11% | +217% from low0% from high | |
| 55Moderate | Roivant Sciences Ltd. | $33M 1,225,784 shares | -7% | +195% from low-3% from high | |
| 55Moderate | Roivant Sciences Ltd. | $39M 1,694,614 shares | -9% | +153% from low0% from high | |
| 55Moderate | Roivant Sciences Ltd. | $26M 1,300,000 shares | -7% | +124% from low-5% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 30, 2026 | ROIV ROIVANT SCIENCES LTD. | 200,000 0.03% of outstanding | $7.1M | Jun 30, 2026 | none |
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | ROIV Roivant Sciences Ltd. | AGrant or award Common Shares | +5,054 | $0.00 | $0 | 1,753,457 | 25 d ago |
| Sep 16, 2026 | ROIV Roivant Sciences Ltd. | AGrant or award Stock Option (Right to Buy)derivative | +10,531 | $0.00 | $0 | 10,531 | 25 d ago |
| Jun 26, 2026 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -300,783 | $33.92 | $10M | 14,826,546 | Jun 30, 2026 |
| Jun 26, 2026 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -325,000 | $34.07 | $11M | 14,501,546 | Jun 30, 2026 |
| Jun 29, 2026 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -200,000 | $34.44 | $6.9M | 14,301,546 | Jun 30, 2026 |
| Jun 29, 2026 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -600,000 | $34.59 | $21M | 13,701,546 | Jun 30, 2026 |
| Jun 30, 2026 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -12,380 | $35.28 | $437k | 13,689,166 | Jun 30, 2026 |
| Jun 30, 2026 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Shares | -200,000 | $35.45 | $7.1M | 1,748,403 | Jun 30, 2026 |
| Feb 11, 2026 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -425,000 | $26.67 | $11M | 15,928,113 | Feb 13, 2026 |
| Feb 12, 2026 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -150,000 | $26.72 | $4.0M | 15,778,113 | Feb 13, 2026 |
| Feb 12, 2026 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -275,000 | $26.76 | $7.4M | 15,503,113 | Feb 13, 2026 |
| Feb 13, 2026 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -150,784 | $26.49 | $4.0M | 15,352,329 | Feb 13, 2026 |
| Feb 13, 2026 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -225,000 | $26.50 | $6.0M | 15,127,329 | Feb 13, 2026 |
| Dec 16, 2025 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -275,000 | $22.93 | $6.3M | 17,772,727 | Dec 18, 2025 |
| Dec 16, 2025 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -642,282 | $23.08 | $15M | 17,130,445 | Dec 18, 2025 |
| Dec 17, 2025 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -432,718 | $23.05 | $10.0M | 16,697,727 | Dec 18, 2025 |
| Dec 17, 2025 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -155,076 | $23.02 | $3.6M | 16,542,651 | Dec 18, 2025 |
| Dec 17, 2025 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -189,538 | $23.17 | $4.4M | 16,353,113 | Dec 18, 2025 |
| Nov 19, 2025 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -850,000 | $20.25 | $17M | 18,497,727 | Nov 21, 2025 |
| Nov 19, 2025 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -150,000 | $20.20 | $3.0M | 18,347,727 | Nov 21, 2025 |
| Nov 19, 2025 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -125,000 | $20.16 | $2.5M | 18,222,727 | Nov 21, 2025 |
| Nov 19, 2025 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -175,000 | $20.24 | $3.5M | 18,047,727 | Nov 21, 2025 |
| Sep 10, 2025 | ROIV Roivant Sciences Ltd. | AGrant or award Common Shares | +14,524 | $0.00 | $0 | 1,948,403 | Sep 12, 2025 |
| Sep 10, 2025 | ROIV Roivant Sciences Ltd. | AGrant or award Stock Option (Right to Buy)derivative | +33,726 | $0.00 | $0 | 33,726 | Sep 12, 2025 |
| Jun 25, 2025 | ROIV Roivant Sciences Ltd. | JOther Common Sharesindirect: Held by QVT Deferred Compensation Holdings Ltd | -6,205,368 | $0.00 | $0 | 8,441,428 | Jun 27, 2025 |
| Jun 25, 2025 | ROIV Roivant Sciences Ltd. | JOther Common Sharesindirect: Held by QVT Financial Investment Cayman Ltd. | -3,176,245 | $0.00 | $0 | 19,347,727 | Jun 27, 2025 |
| Jun 25, 2025 | ROIV Roivant Sciences Ltd. | JOther Common Sharesindirect: Held by QVT Roiv Hldgs Onshore Ltd. | -6,837,266 | $0.00 | $0 | 0 | Jun 27, 2025 |
| Jun 25, 2025 | ROIV Roivant Sciences Ltd. | JOther Common Sharesindirect: Held by QVT P&E Roiv Hldgs Ltd. | -1,170,646 | $0.00 | $0 | 1,592,480 | Jun 27, 2025 |
Questions about Keith S Manchester
Answered from the filings on this page, as of the latest one.
Is Keith S Manchester buying or selling?
In the last 12 months Keith S Manchester reported 0 open-market buys worth $0 and 4 open-market sells worth $154M on SEC Form 4; the latest was sold $56M of ROIV on Jun 26, 2026. Grants, option exercises and tax withholding are not counted.
How did Keith S Manchester's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Keith S Manchester has 0.
Where does Keith S Manchester file Form 4?
Keith S Manchester has filed Form 4 at ROIV (Roivant Sciences Ltd.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.